ABSTRACT. Hyperuricemic nephropathy can progress to the permanent renal damage even in infancy in partial hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. We have encountered two unrelated patients with partial HPRT deficiency, and found that early detection of the disease and long-term management for hyperuricemia were necessary to prevent renal impairment. The HPRT gene is situated in the q26-27 region of the long arm of the X-chromosome, and females with mutant HPRT alleles are heterozygous for the disease, and they develop gout after menopause. We undertook the investigation of carriers in the two patients' families, using BamHI restriction fragment length polymorphisms and oligonucleotide probes that recognized the specific mutations within the HPRT gene. We also demonstrated that the allele frequencies of BamHI restriction fragment length polymorphisms in 62 Japanese females were 0.36 for the 22-kb/25-kb allele, 0.41 for the 12-kb/25-kb allele, and 0.23 for the 22-kb/l8-kb allele, resulting in a heterozygous state in 66% of females. (Pediatr Res 27: 417-421, 1990) Abbreviations HPRT, hypoxanthine-guanine phosphoribosyltransferase RFLP, restriction fragment length polymorphisms LN, Lesch-Nyhan
ABSTRACT. Hyperuricemic nephropathy can progress to the permanent renal damage even in infancy in partial hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. We have encountered two unrelated patients with partial HPRT deficiency, and found that early detection of the disease and long-term management for hyperuricemia were necessary to prevent renal impairment. The HPRT gene is situated in the q26-27 region of the long arm of the X-chromosome, and females with mutant HPRT alleles are heterozygous for the disease, and they develop gout after menopause. We undertook the investigation of carriers in the two patients' families, using BamHI restriction fragment length polymorphisms and oligonucleotide probes that recognized the specific mutations within the HPRT gene. We also demonstrated that the allele frequencies of BamHI restriction fragment length polymorphisms in 62 Japanese females were 0.36 for the 22-kb/25-kb allele, 0.41 for the 12-kb/25-kb allele, and 0.23 for the 22-kb/l8-kb allele, resulting in a heterozygous state in 66% of females. (Pediatr Res 27: 417-421, 1990) Abbreviations HPRT, hypoxanthine-guanine phosphoribosyltransferase RFLP, restriction fragment length polymorphisms LN, Lesch-Nyhan Deficiency of the enzyme HPRT (E.C.2.4.2.8) is associated with two clinical syndromes (1, 2) . Complete absence of enzyme activity is responsible for LN syndrome, which is characterized by hyperuricemia, choreoathetosis, muscle spasticity, mental retardation, and compulsive self-mutilation (3). Patients with a partial deficiency of the enzyme activity are spared the devastating neurologic and behavioral abnormalities of LN syndrome (4). However, they present with hyperuricemia and a severe form of gout at an early age (5) . Several recent reports have indicated that patients with partial HPRT deficiency or suspected LN syndrome can develop acute renal failure due to uric acid nephropathy in early infancy (6) (7) (8) . Therefore, evaluation ofthe serum level of uric acid is necessary in male babies born to mothers who are the carriers of partial HPRT deficiency. If the male infant has hyperuricemia, fluid supplements and administration of allopurinol are necessary to prevent neonatal acute uric acid nephropathy. Carrier women have an overproduction of uric acid throughout their lives. After menopause, the endogenous production of uricosuric estrogens declines, and the serum uric acid level increases resulting in gout (9) . Thus, a reliable method to detect the camer state is needed to help both these patients groups.
HPRT enzyme assay in erythrocytes or lymphoblasts is not able to discriminate the carrier state from normal, as erythrocytes or lymphoblasts from canier women often show normal HPRT enzyme activity (10) . Camer state detection in LN syndrome has been performed by the demonstration of mosaicism for HPRT' and HPRT-clones of fibroblasts or lymphocytes and by the demonstration of two populations of hair roots, those with normal and those with either zero or subnormal levels of HPRT activity ( 1 1-1 6) . The use of cells from hair follicles imposes logistical problems, and there is also evidence that each hair follicle is not truly clonal but is derived from two or three different cells (13, 17) . Furthermore, both of these methods are time-consuming and although carriers can be identified, it is difficult to be sure that a negative result is absolutely reliable. These methods have not yet been applied to detecting the carrier state of partial HPRT deficiency. The clones derived from 8-azaguanine-or 3-thioguanine-resistant cells from LN syndrome heterozygotes had the phenotype of HPRT-deficient cells since they did not incorporate hypoxanthine and had almost no HPRT activity. However, it was often impossible to demonstrate mosaicism with respect to HPRT' and partial HPRT' clones in partial HPRT deficiency; the partial HPRT+ clone was often not resistant to either 8-azaguanine or 3-thio-guanine. Gibbs et al. (18) recently demonstrated the usefulness of BamHI RFLP in diagnosis of the carriage of LN syndrome. Twenty of 28 women, whose carrier state could not be determined by pedigree analysis or who were apparently normal according to the biochemical tests, were diagnosed as definite camers on the basis of the RFLP analysis.
We have recently shown molecular abnormalities in two unrelated patients with partial HPRT deficiency. 1 ) Two singlebase substitutions were detected at codon 179 (from GTT to GGT) and codon 180 (from GGA to AGA), resulting in the putative replacement of valine with glycine and glycine with arginine.
2) The deletion of 5 1 nucleotides between nucleotides 747 and 797 was also found, resulting in the formation of a shorter HPRT mRNA and a putative two amino acid-deleted HPRT protein (19) . In this study, we applied both oligonucleotide hybridization techniques and BamHI RFLP analysis to identify carriers in two unrelated families with partial HPRT deficiency. 4 
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Subjects.
Nine subjects belonging to two families with partial HPRT deficiency were studied. In addition, 62 normal females were analyzed by Southern blotting to determine the average level of heterozygosity for BamHI RFLP. Red cell lysates and enzyme assays. Red cell lysates were prepared from heparinized venous blood by centrifugation at 70 x g for 10 min followed by removal of plasma and the buffy coat. Red cells were washed four times for an equal volume of PBS at 4°C. Packed red cells were suspended in an equal volume of 10 mmol phosphate (pH 7.3) and lysed by sonication. Lysates were centrifuged at 7000 x g for 30 min and the supernatants were recovered for assay at -70°C.
Sensitive radiochemical techniques were used to quantify HPRT enzyme activity in 50 mmol Tris-HC1 (pH 7. 
DNA isolation and Southern blot analysis. High mol wt DNA
was isolated from peripheral blood samples as described in the literature (21) . DNA samples of 7.5 pg were digested to completion with restriction endonuclease BamHI (Boehringer Mannheim GmbH, Mannheim, FRG) at a concentration of 5 U/pL, and fractionated in 0.8% agarose gels (Ultrapure agarose, Bethesda Research Laboratories, Gaithersburg, MD) treated according to the method of Whal et al. (22) . Samples were then transferred into nitrocellulose filters and hybridized with 32P-deoxycytidine triphosphate labeled full-length HPRT cDNA (pHP31; provided by Dr. W. N. Kelley) (sp act of more than 3000 Ci/mmol, Amersham Japan, Tokyo, Japan). Probes were labeled to a sp act of 1-3 X lo8 cpm/pg using a multiprime DNA labeling system (Amersham Japan). Hybridization was canied out at 42°C in a mixture containing 50% formamide. Hybridization patterns were visualized by autoradiography. Probe C (5'-TCAACTTGAACTCTCATC-3') was complementary to normal HPRT cDNA and ranged between nucleotides 757 and 774, the region that was considered to possibly be deleted from the HPRT cDNA of patient M.T. Genomic DNA samples of 20 pg were applied directly by the dot-blot method onto nitrocellulose filters and analyzed by hybridization with oligonucleotide probes. Probes were labeled by 32P-adenosine triphosphate (sp act of more than 3000 Ci/mmol, Amersham Japan) using T4 polynucleotide kinase (New England BioLabs). The hybridization temperature was specific to each probe, being 43°C for probe A, 41°C for probe B, and 45°C for probe C (24). Hybridization patterns were visualized by autoradiography.
Oligonucleotide synthesis and dot-blot analysis of genomic

CASE REPORTS
Family A. T.A. was born without complications on 8/7/1977. The birth wt was 3100 g. Both parents were healthy and there was no history of gout in either parent's family. Large amounts of orange colored crystals were seen in the diapers when the patient was 3 mo old. Hyperuricemia (serum uric acid 6.8 nmol/ L) was found, and administration of allopurinol was started by the local hospital. The erythrocyte HPRT activity was determined at Tokyo University Hospital. This was less than 0.7% of the normal value, and LN syndrome was suspected initially. With careful control, the serum uric acid level was kept less than 3.8 nmol/L and the renal function remained within normal limits. The patient showed normal development without any of the neurologic symptoms that are characteristic of LN syndrome. HPRT activity in B cell lymphoblasts was determined in 1979 to be 3.9% of the normal value. The low HPRT activity in his lymphoblasts, together with the clinical course, made the diagnosis partial HPRT deficiency. A brother was born normally on 912 1/1980. He also showed hyperuricemia (serum uric acid 7.1 nmol/L) and negative erythrocyte HPRT activity (less than 0.7% of the normal value), and was started on allopurinol. Both of them are currently healthy, without any attacks of gout, urolithiasis, renal impairment, or neurologic symptoms.
Family B. M.T. was born healthy on 12/19/1972. The mother's brothers had gout and were being treated with allopurinol. The patient had a urinary calculus in 1982, and several episodes of swelling of the right big toe joint in 1983 and 1984. He presented to Tokyo University Hospital in 1984. Hyperuricemia (serum uric acid 7.6 nmol/L) was found, and administration of allopurinol was started. Radiographic examination demonstrated periarticular bone resorption in the joints of the big toes. The creatinine clearance was 48 mL/min/1.73 m2 and urinary P-2 microglobulin excretion was increased (4574 pg/day). The arterial concentration of HC03-was 24 mmol/L. The erythrocyte HPRT activity was 9.8% of the control level, and therefore partial HPRT deficiency was diagnosed. He did not have any of the neurologic symptoms that are seen in LN syndrome. With treatment, the serum uric acid level was kept less than 3.8 nmol/L. However, the impairment of creatinine clearance and the hyper-P-2 microglobulinuria (3470 pg/day) persisted.
RESULTS
Erythrocyte HPRT enzyme activity (Table 1, Fig. I ). The erythrocyte HPRT enzyme activity levels are summarized in Table 1 . HPRT enzyme activity was undetectable in erythrocytes (less than 0.7% of the control) from patients 111.1 and 111.2 of family A. It was decreased to 9.8% of the control level in patient 111.1 from family B. Carrier mothers 11.2 from family A and 11.3 from family B showed normal HPRT activity. Members 11.1 from family A (the sister of camer mother) and 111.3 from family B (the daughter of carrier mother) also showed normal HPRT activity.
Southern blot analysis of the HPRT gene (Fig. 2) . BamHII RFLP were expressed phenotypically on Southern blots as three distinct pairs of fragments in normal Caucasian and Japanese population: a 22-kb/25-kb pair (frequency in the Caucasian population 0.77); a 12-kb/25-kb pair (0.16); and a 22-kb/18-kb pair (0.07) (25) .
In family A, members 111.1 (the propositus) and 111.2 (his brother) had the 22-kb/25-kb allele, and members I. 1 (his grandmother, a suspected carrier), 11.2 (the carrier mother) and 11.1 (the sister) also showed the double 22-kb/25-kb pattern. Therefore, it was not possible to identify which of their X chromosomes carried the mutant gene, the BamHI polymorphism analysis was not helpful.
In family B, member 111.1 (the propositus) had the 22-kb/18-kb allele that therefore marked the X-chromosome carrying the mutant HPRT gene. Member 11.4, the father of the propositus, had the 22-kb/25-kb allele, whereas member 11.-3 (the carrier mother) showed the combination of a 22-kb/18-kb allele and a 12-kb/25-kb allele. Member 111.3, the sister of the propositus, had the combination of 22-kb/25-kb and 22-kb/18-kb, and she was thus considered to be a carrier. The BamHI polymorphism analysis was therefore quite informative in this family.
Dot-blot analysis with oligonucleotide probes (Figs. 3 and 4) . Genomic DNA from family members 11.1 (the sister of the carrier mother), 11.2 (the camer mother), and 11.3 (the father) of family A and a family control hybridized to normal probe A, which was complementary to normal HPRT cDNA ranging between nucleotides 628 and 645. The control dot appeared to be twice the intensity of the dots from members 11.2 and 11.3 However, genomic DNA from family members 111.1 (the propositus) and 111.2 did not hybridize to the probe A. However, genomic DNA from members 11.1, 11.2, 111.1, and 111.2 of family A hybridized to the mutant probe B, which was complementary to a putative mutant HPRT cDNA ranging between nucleotides 628 and 645 420 IGARASHI ANC 1 KAMOSHITA in the propositus. Genomic DNA from members 11.3 and a female control did not hybridize to the probe B. These results implied that member 11.1 was a carrier. Although BamHI RFLP analysis had not been informative in this family, analysis with patient-specific and normal oligonucleotide probes was able to diagnose a carrier.
Genomic DNA from members 11.3 (the carrier mother), 11.4 (the father), and 111.3 (the daughter) in family B hybridized to the probe C, which was complementary to normal HPRT cDNA ranging between nucleotides 757 and 774. Genomic DNA from member 111.1 (the propositus) did not hybridize to probe C, because the region complementary to the probe was included in the 5 1 nucleotide deletion in the HPRT gene of the patient. The dot intensity of the carrier mother was almost equal to that of the daughter (III.3), and the intensity of the dot from the control female was almost twice as strong implying that 111.3 was a carrier. This agreed with the result of the BamHI RFLP analysis.
Population study ( Table 2) . A survey of the BamHI RFLP phenotypes from 62 unrelated Japanese females is summarized in Table 2 . Overall, 36% of X chromosomes carried the 22-kb/ 25-kb allele, 41% carried the 12-kb/25-kb allele, and 23% had the 22-kb/18-kb allele. Given these allele frequencies, 66% of Japanese females were heterozygous with respect to BamHI RFLP.
DISCUSSION
Hyperuricemia is known to cause hyperuricemic nephropathy in which deposition of uric acid crystals in the tubules leads to rupture of the tubular basement membrane and thus to more severe interstitial and glomerular involvement. Recurrent episodes of nephropathy, either symptomatic or nonsymptomatic, can progress to permanent renal impairment (26) . We encountered two patients with partial HPRT deficiency, and found that early detection of the disease and long-term management of hyperuricemia is mandatory to prevent renal impairment in this disease.
BamHI RFLP analysis was informative to detect carriers of partial HPRT deficiency in family B, but was not helpful in family A. An additional Tag1 RFLP, which has been reported for an anonymous sequence (DXS-10) closely linked to HPRT locus, can be applied to detect carriers in family A (27) .
Hybridization analysis of amplified or unamplified genomic DNA with mutant oligonucleotide probes is also known to be feasible for carrier detection (28, 29) . When BamHI RFLP analysis was noninformative, genotypes could still be partially distinguished by direct analysis of mutation sites within the HPRT gene. Dot blot analysis with normal and mutant oligonucleotide probes clearly separated the normal members, the carrier, and the patient in family A. Moreover, dot-blot analysis with normal oligonucleotide probe confirmed the result shown by BamHI RFLP analysis in family B.
For determination of carrier status in the at-risk daughter of a carrier mother using BumHI RFLP analysis, it is necessary to identify which chromosome canies the HPRT mutant gene in the mother. Thus, she must be heterozygous with respect to the BamHI RFLP phenotype. Nussbaum et al. (25) surveyed 83 independent X chromosomes from 30 families for BamHI RFLP, and reported that the allele frequencies in the Caucasian population were 0.77 for the 22-kb/25-kb allele, 0.16 for the 12-kb/25-kb allele, and 0.07 for the 22-kb/18-kb allele, resulting in an average heterozygosity of 38% in females. However, our study showed that the allele frequencies in the Japanese female population were 0.36 for the 22-kb/25-kb allele, 0.41 for the 12-kb/ 25-kb allele, and 0.23 for the 22-kb/18-kb allele, indicating that 66% of Japanese females were heterozygous for BamHI RFLP, a higher rate than in Caucasian females. In this respect, we cannot exclude the possibility that racial factors contributed to the different results of the two studies. No difference has been found between the frequencies of the BamHI RFLP in normal X chromosomes, X chromosomes bearing HPRT mutations, and X chromosomes in individuals with a variety of X-linked diseases (25) .
Accordingly, BamHI RFLP analysis could be applied to the families with the disease more effectively in Japan than in countries with a predominantly Caucasian population.
